{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:04:17Z","timestamp":1791288257943,"version":"4.3.0"},"reference-count":31,"publisher":"American Association for Cancer Research (AACR)","issue":"4","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several reports have shown that the EBV-encoded BARF1 gene has oncogenic activity. We have recently reported that BARF1 is expressed as a latent gene in most nasopharyngeal carcinomas (NPC), suggesting that BARF1 may have an important role in NPC oncogenesis. However, we found that when the NPC-derived EBV-negative cell lines, HONE-1 and CNE-1, were infected with EBV in vitro, BARF1 was not expressed, although the expression of other latent genes was identical to that of NPC tumors. Therefore, we generated a recombinant EBV (rEBV) carrying the BARF1 gene (BARF1-rEBV) under the SV40 promoter to reconstitute the NPC-type EBV infection. NPC-derived EBV-negative cell lines were stably infected with either a wild-type rEBV (wild-rEBV) or BARF1-rEBV. The resultant BARF1-rEBV\u2013infected NPC cell clones represented NPC-type EBV expression, and BARF1 expression was similar to that observed in NPC tissues. BARF1-rEBV\u2013infected cell clones grew to a higher cell density and were more resistant to apoptosis than wild-rEBV\u2013infected counterparts. BARF1 protein was quickly secreted into the culture medium, and secreted BARF1 contributed to the increase of cell densities in NPC cells, but it had no effect on resistance to apoptosis. Furthermore, BARF1-rEBV\u2013infected cell clones became tumorigenic in nude mice. These results suggest that BARF1 plays an important role in NPC development. [Cancer Res 2008;68(4):1030\u20136]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-5252","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T14:07:20Z","timestamp":1203084440000},"page":"1030-1036","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Reconstitution of Nasopharyngeal Carcinoma\u2013Type EBV Infection Induces Tumorigenicity"],"prefix":"10.1158","volume":"68","author":[{"given":"Eri","family":"Seto","sequence":"first","affiliation":[{"name":"1Department of Tumor Virology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadamasa","family":"Ooka","sequence":"additional","affiliation":[{"name":"2Laboratoire de Virologie Moleculaire, Centre National de la Recherche Scientifique, Faculte de Medecine R.T.H. Laennec, Universite Claude Bernard Lyon-1, Lyon, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Takada","sequence":"additional","affiliation":[{"name":"1Department of Tumor Virology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,2,15]]},"reference":[{"key":"2022061700404901200_B1","doi-asserted-by":"crossref","unstructured":"Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol\u20082002; 12: 421\u20139.","DOI":"10.1016\/S1044579X02000858"},{"key":"2022061700404901200_B2","doi-asserted-by":"crossref","unstructured":"Spano JP, Busson P, Atlan D, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer\u20082003; 39: 2121\u201335.","DOI":"10.1016\/S0959-8049(03)00367-8"},{"key":"2022061700404901200_B3","doi-asserted-by":"crossref","unstructured":"Li XP, Li G, Peng Y, Kung HF, Lin MC. Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem Biophys Res Commun\u20082004; 315: 212\u20138.","DOI":"10.1016\/j.bbrc.2004.01.045"},{"key":"2022061700404901200_B4","unstructured":"Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia (PA): Lippincott-Raven; 2002. p. 2575\u2013627."},{"key":"2022061700404901200_B5","unstructured":"Ooka T. BARF-1 gene as an EBV encoded oncogene. Epstein Barr Virus Report\u20082001; 8: 177\u201382."},{"key":"2022061700404901200_B6","doi-asserted-by":"crossref","unstructured":"Wei MX, Ooka T. A transforming function of the BARF1 gene encoded by Epstein-Barr virus. EMBO J\u20081989; 8: 2897\u2013903.","DOI":"10.1002\/j.1460-2075.1989.tb08438.x"},{"key":"2022061700404901200_B7","doi-asserted-by":"crossref","unstructured":"Sheng W, Decaussin G, Sumner S, Ooka T. N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2. Oncogene\u20082001; 20: 1176\u201385.","DOI":"10.1038\/sj.onc.1204217"},{"key":"2022061700404901200_B8","doi-asserted-by":"crossref","unstructured":"Sheng W, Decaussin G, Ligout A, Takada K, Ooka T. Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol\u20082003; 77: 3859\u201365.","DOI":"10.1128\/JVI.77.6.3859-3865.2003"},{"key":"2022061700404901200_B9","unstructured":"Wei MX, Moulin JC, Decaussin G, Berger F, Ooka T. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line. Cancer Res\u20081994; 54: 1843\u20138."},{"key":"2022061700404901200_B10","doi-asserted-by":"crossref","unstructured":"Wei MX, De Turenne-Tessier M, Decaussin G, Benet G, Ooka T. Establishment of a monkey epithelial cell line with the BARF1 open reading frame from Epstein-Barr virus. Oncogene\u20081997; 14: 3073\u201381.","DOI":"10.1038\/sj.onc.1201128"},{"key":"2022061700404901200_B11","doi-asserted-by":"crossref","unstructured":"Danve C, Decaussin G, Busson P, Ooka T. Growth transformation of primary epithelial cells with a NPC-derived Epstein-Barr virus strain. Virology\u20082001; 288: 223\u201335.","DOI":"10.1006\/viro.2001.1072"},{"key":"2022061700404901200_B12","doi-asserted-by":"crossref","unstructured":"Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson, AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. EMBO J\u20081992; 66: 122\u201331.","DOI":"10.1128\/jvi.66.1.122-131.1992"},{"key":"2022061700404901200_B13","doi-asserted-by":"crossref","unstructured":"Brink AATP, Vervoort MBHJ, Middeldorp JM, Meijer CJLM, Vandenbrule AJC. Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR. J Clin Microbiol\u20081998; 36: 3164\u20139.","DOI":"10.1128\/JCM.36.11.3164-3169.1998"},{"key":"2022061700404901200_B14","unstructured":"Decaussin G, Sbih-Lammali F, De Turenne-Tessier M, Bouguermouh A, Ooka T. Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res\u20082000; 60: 5584\u20138."},{"key":"2022061700404901200_B15","doi-asserted-by":"crossref","unstructured":"Hayes DP, Brink AATP, Vervoort MBHJ, Middeldorp JM, Meijer CJLM, Vandenbrule AJC. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. J Clin Pathol Mol Pathol\u20081999; 52: 97\u2013103.","DOI":"10.1136\/mp.52.2.97"},{"key":"2022061700404901200_B16","doi-asserted-by":"crossref","unstructured":"Stevens SJ, Verkuijlen SA, Hariwiyanto B, et al. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer\u20082006; 119: 608\u201314.","DOI":"10.1002\/ijc.21914"},{"key":"2022061700404901200_B17","doi-asserted-by":"crossref","unstructured":"Zhang CX, Decaussin G, Daillie J, Ooka T. Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J Virol\u20081988; 62: 1862\u20139.","DOI":"10.1128\/jvi.62.6.1862-1869.1988"},{"key":"2022061700404901200_B18","unstructured":"Kieff E, Rickinson AB. Epstein-Barr virus and its replication, In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia (PA): Lippincott-Raven; 2002. p. 2511\u201373."},{"key":"2022061700404901200_B19","doi-asserted-by":"crossref","unstructured":"Seto E, Yang L, Middeldorp JM, et al. Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol\u20082005; 76: 82\u20138.","DOI":"10.1002\/jmv.20327"},{"key":"2022061700404901200_B20","doi-asserted-by":"crossref","unstructured":"Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol\u20081998; 72: 4371\u20138.","DOI":"10.1128\/JVI.72.5.4371-4378.1998"},{"key":"2022061700404901200_B21","doi-asserted-by":"crossref","unstructured":"Glaser R, Zhang HY, Yao KT, et al. Two epithelial tumor cell lines (HNE-1and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A\u20081989; 86: 9324\u20138.","DOI":"10.1073\/pnas.86.23.9524"},{"key":"2022061700404901200_B22","unstructured":"Deng ZW, Li YYB, Sun HC, Yao TH. Infection of nasopharyngeal carcinoma cells (CNE line) with Epstein-Barr virus. Acta Biologie Experimentalis Sinica\u20081981; 14: 271\u20134 (in Chinese)."},{"key":"2022061700404901200_B23","doi-asserted-by":"crossref","unstructured":"Maruo S, Yang L, Takada K. Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J Gen Virol\u20082001; 82: 2373\u201383.","DOI":"10.1099\/0022-1317-82-10-2373"},{"key":"2022061700404901200_B24","doi-asserted-by":"crossref","unstructured":"Shimizu N, Yoshiyama H, Takada K. Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol\u20081996; 70: 7260\u20133.","DOI":"10.1128\/jvi.70.10.7260-7263.1996"},{"key":"2022061700404901200_B25","doi-asserted-by":"crossref","unstructured":"Takada K, Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol\u20081989; 63: 445.","DOI":"10.1128\/jvi.63.1.445-449.1989"},{"key":"2022061700404901200_B26","doi-asserted-by":"crossref","unstructured":"Strockbine LD, Cohen JI, Farrah T, et al. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol\u20081998; 72: 4015\u201321.","DOI":"10.1128\/JVI.72.5.4015-4021.1998"},{"key":"2022061700404901200_B27","doi-asserted-by":"crossref","unstructured":"Sherr CJ. Colony-stimulating factor-1 receptor. Blood\u20081990; 75: 1\u201312.","DOI":"10.1182\/blood.V75.1.1.1"},{"key":"2022061700404901200_B28","doi-asserted-by":"crossref","unstructured":"Sall A, Caserta S, Jolicoeur P, Franqueville L, De Turenne-Tessier M, Ooka T. Mitogenic activity of Epstein-Barr virus-encoded BARF1 protein. Oncogene\u20082004; 23: 4938\u201344.","DOI":"10.1038\/sj.onc.1207607"},{"key":"2022061700404901200_B29","doi-asserted-by":"crossref","unstructured":"Busson P, Ganem G, Flores P, et al. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer\u20081988; 42: 599\u2013606.","DOI":"10.1002\/ijc.2910420422"},{"key":"2022061700404901200_B30","doi-asserted-by":"crossref","unstructured":"Tsao SW, Tramoutanis G, Dawson CW, Lo AKF, Huang DP. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol\u20082002; 12: 473\u201387.","DOI":"10.1016\/S1044579X02000901"},{"key":"2022061700404901200_B31","doi-asserted-by":"crossref","unstructured":"Karim H, Xiaohui W, Yuko S, et al. A new diagnostic marker for secreted Epstein-Barr virus-encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res\u20082007; 13: 4993\u20135000.","DOI":"10.1158\/1078-0432.CCR-06-2945"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/4\/1030\/2599941\/1030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/4\/1030\/2599941\/1030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:07:40Z","timestamp":1655431660000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/4\/1030\/542228\/Reconstitution-of-Nasopharyngeal-Carcinoma-Type"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,15]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,2,15]]},"published-print":{"date-parts":[[2008,2,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-5252","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22374896.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497636.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374899.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374896","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6497636","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22374899","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,15]]}}}